Cresco Labs Inc. (CRLBF) Change in Accured Expenses (2020 - 2026)

Cresco Labs (CRLBF) has reported Change in Accured Expenses for 7 consecutive years, with -$356000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 96.65% year-over-year to -$356000.0; the trailing twelve-month figure through Jun 2026 stood at -$2.7 million (down 78.1% YoY), and the FY2025 full-year result was $8.6 million, up 150.94% from the prior year.
• Change in Accured Expenses advanced to -$356000.0 in Q2 2026 per CRLBF's latest filing, from -$7.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $20.1 million in Q1 2023 and bottomed at -$20.5 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged $1.2 million across 5 years, with a median of -$2.2 million in 2022.
• The widest YoY moves for Change in Accured Expenses: up 38751.28% in 2022, down 398300.0% in 2022.
• Over 5 years, Change in Accured Expenses stood at -$4.0 million in 2022, then sank by 188.98% to -$11.5 million in 2023, then sank by 77.9% to -$20.5 million in 2024, then soared by 151.87% to $10.6 million in 2025, then slumped by 103.35% to -$356000.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$356000.0, -$7.6 million, and $10.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.